Analysis of Factors Associated With Pathological Complete Response in Patients With HER2-Positive Breast Cancer Receiving Neoadjuvant Chemotherapy
Clinical Breast Cancer · 2024
DOI: 10.1016/j.clbc.2024.08.010 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Breast Cancer, 2024. Verfasst von Neda Stjepanovic und 8 weiteren Autor:innen. Beteiligte Einrichtung: Division of Medical Oncology and Hematology, Sunnybrook Odette Cancer Centre, Toronto, ON, Canada. Hauptthemen laut MEDLINE: Breast Neoplasms, Neoadjuvant Therapy, Erb-b2 Receptor Tyrosine Kinases, Antineoplastic Combined Chemotherapy Protocols. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Themen: Onkologische Pflege
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Medical Oncology and Hematology, Sunnybrook Odette Cancer Centre, Toronto, ON, Canada.
- Division of Medical Oncology and Hematology, Sunnybrook Odette Cancer Centre, Toronto, ON, Canada; Department of Medicine, University of Toronto, Toronto, ON, Canada.
- Research Design and Biostatistics, Sunnybrook Research Institute, Toronto, ON, Canada.
- Evaluative Clinical Sciences, Odette Cancer Research Program, Sunnybrook Research Institute, Toronto, ON, Canada; Department of Radiation Oncology, Sunnybrook Health Sciences Centre, Toronto, ON, Canada.
- Division of Medical Oncology and Hematology, Sunnybrook Odette Cancer Centre, Toronto, ON, Canada; Department of Medicine, University of Toronto, Toronto, ON, Canada. Electronic address: rossanna.pezo@sunnybrook.ca.
Zitieren
APA
Stjepanovic, N., Kumar, S., Jerzak, K. J., Trudeau, M., Warner, E., Cao, X., Eisen, A., Tran, W., & Pezo, R. C. (2024). Analysis of Factors Associated With Pathological Complete Response in Patients With HER2-Positive Breast Cancer Receiving Neoadjuvant Chemotherapy. Clinical Breast Cancer. https://doi.org/10.1016/j.clbc.2024.08.010
Vancouver
Stjepanovic N, Kumar S, Jerzak KJ, Trudeau M, Warner E, Cao X, et al. Analysis of Factors Associated With Pathological Complete Response in Patients With HER2-Positive Breast Cancer Receiving Neoadjuvant Chemotherapy. Clinical Breast Cancer. 2024. doi:10.1016/j.clbc.2024.08.010
BibTeX
@article{Stjepanovic2024,
author = {Stjepanovic, Neda and Kumar, Sudhir and Jerzak, Katarzyna J and Trudeau, Maureen and Warner, Ellen and Cao, Xingshan and Eisen, Andrea and Tran, William and Pezo, Rossanna C},
title = {Analysis of Factors Associated With Pathological Complete Response in Patients With HER2-Positive Breast Cancer Receiving Neoadjuvant Chemotherapy},
journal = {Clinical Breast Cancer},
year = {2024},
doi = {10.1016/j.clbc.2024.08.010}
}
EUVIMED